Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program StudyZijun Y. Xu‐Monette, Ken H. Young, Xiaoying Zhao et al.|Blood|2012Cited by 390
TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancerWei Xu, Jianwei Zhou|Cell Death and Disease|2014Cited by 84
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cellsWei Xu, Jianwei Zhou|Cell Death and Disease|2014Cited by 58
Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinibWei Xu, Jianqing Wu|Cell & Bioscience|2015Cited by 50
miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylationZhi‐Jian Zou, Wei Xu|Oncotarget|2014Cited by 43